Of these adipokines, adiponectin has been widely focused for its anti-diabetic and anti-atherogenic effects and is expected to be a novel therapeutic tool for diabetes and the metabolic syndrome (Kadowaki and Yamauchi, 2005). The gene discussed is ADIPOQ; the disease is metabolic syndrome.